AdaptOS™ Atlas Vertical: AI in Pharma - Biotech 2026

From hypothesis to approval: target triage, cohort matching, protocol compilers, RBQM signal mining, CMC set-point control—40 pilotable solutions.

Biotech scales on assay quality, trial velocity, compliance posture, and market access. This pack tackles science-to-revenue: multimodal retrieval for evidence, screen-fail reduction, amendment discipline, clause-linked labeling, bioreactor reliability, and payer-grade narrative conversion.

What you get: 40 solutions mapped to the AdaptOS™ Atlas locked schema to align AI adoption with your current tech stack—segment shifts, strategic imperatives, adoption sequencing, solution clusters, value-compounding paths, governance & trust anchors, risk & resistance playbooks, board-level guardrails, RFP-ready vendor-analog references (non-endorsement), KPI-anchored 90-day pilots, buyer personas, HITL boundaries, and integration/data/security notes—so you can sequence action and defend spend with evidence in 2026.